Oncology |
Azacitidine
|
|
|
100 mg |
Filed |
|
Oncology |
Bendamustine
|
|
|
25, 100mg |
Filed |
|
Oncology |
Bendamustine RTU
|
|
|
180 mg/ 4 ml, 100 mg/ 4 ml |
Filed |
|
Oncology |
Bortezomib
|
|
|
3.5 mg |
Filed |
|
Oncology |
Cabazitaxel
|
|
|
60 mg/ 1.5 ml |
Filed |
|
Oncology |
Carfilzomib
|
|
|
30 mg/ml, 60 mg/ml |
Filed |
|
Oncology |
Decitabine
|
|
|
50 mg |
Filed |
|
Oncology |
Eribulin
|
|
|
1 mg/2 ml |
Under Development |
|
Oncology |
Fulvestrant
|
|
|
50 mg/ml |
Filed |
|
Oncology |
Fosaprepitant
|
|
|
150 mg/ ml |
Filed |
|
Oncology |
Liposomal Doxorubicin
|
|
|
20 mg/10 ml ,50 mg/25 ml |
Filed |
|
Oncology |
Palonosetron
|
|
|
0.075 mg/5 ml, 0.25 mg/ 5 ml |
Filed |
|
Oncology |
Pemetrexed
|
|
|
100 mg, 500 mg, 1000 mg |
Filed |
|
Oncology |
Plerixafor
|
|
|
24 mg/1.2 ml |
Filed |
|
Oncology |
Zoledronic Acid
|
|
|
4 mg/5 ml, 5 mg/100 ml, 4 mg/100 ml |
Filed |
|
Oncology |
Abiraterone
|
|
|
250 mg |
Filed |
|
Oncology |
Abiraterone
|
|
|
500 mg |
Under Development |
|
Oncology |
Capecitabine
|
|
|
150 mg, 500 mg |
Filed |
|
Oncology |
Dasatinib
|
|
|
20, 50, 70, 80,100 and 140 mg |
Filed |
|
Oncology |
Enzalutamide
|
|
|
40 mg |
Under Development |
|
Oncology |
Everolimus
|
|
|
2.5, 5, 7.5, 10 mg |
Under Development |
|
Oncology |
Lenalidomide
|
|
|
2.5, 5, 10, 15, 20, 25 mg |
Filed |
|
Oncology |
Lenvatinib
|
|
|
4, 10 mg |
Under Development |
|
Oncology |
Nilotinib
|
|
|
150, 200 mg |
Under Development |
|
Oncology |
Palbociclib
|
|
|
75, 100, 125 mg |
Filed |
|
Oncology |
Pomalidomide
|
|
|
1,2,3,4 mg |
Filed |
|
Oncology |
Imatinib Mesylate
|
|
|
100 MG AND 400 MG |
Filed |
|
Oncology |
Carmustine
|
|
|
100 mg/vial |
Filed |
|
Oncology |
Venetoclax
|
|
|
10 mg, 50 mg and 100 mg |
Filed |
|
Oncology |
Sorafenib
|
|
|
200 mg |
Filed |
|
Oncology |
Midostaurin
|
|
|
25 mg |
Filed |
|
Oncology |
Sunitinib Malate
|
|
|
12.5 mg, 25 mg, 37.5 mg and 50 mg |
Filed |
|
Oncology |
Nano Paclitaxel
|
|
|
100mg |
Under Development |
|
Oncology |
Axitinib
|
|
|
1mg, 3mg, 5mg, 7mg |
Under Development |
|
Oncology |
Cabozantinib
|
|
|
20 mg, 40 mg and 60 mg |
Under Development |
|
Oncology |
Sunitinib
|
|
|
12.5Mg;25Mg;37.5Mg;50Mg |
Filed |
|
Oncology |
Tofacitinib XR
|
|
|
Tofacitinib XR |
Under Development |
|
Oncology |
Pazopanib
|
|
|
200 and 400 mg |
Under Development |
|
Oncology |
Nintedanib
|
|
|
100 mg & 150 mg |
Under Development |
|
Oncology / Acromegaly |
Octerotide
|
|
|
10mg, 20mg & 30mg |
Under Development |
|
Oncology / Acromegaly |
Lanreotide
|
|
|
60mg/0.2mL, 90mg/0.3mL and 120mg/0.5mL |
Under Development |
|
Central Nervous System |
Glatiramer
|
|
|
20, 40 mg |
Filed |
|
Central Nervous System |
Sugammadex
|
|
|
100 mg/ml |
Filed |
|
Central Nervous System |
Pregabalin
|
|
|
25, 50, 75, 100, 150, 200, 225, 300 mg |
Filed |
|
Oncology |
Fingolimod
|
|
|
0.5 mg |
Filed |
|
Cardiovascular |
Fondaparinux
|
|
|
2.5, 5, 7.5, 10mg |
Filed |
|
Oncology |
Dimethyl Fumarate
|
|
|
120mg, 240mg |
Under Development |
|
Cardiovascular |
Treprostinil
|
|
|
1, 2.5, 5, 10mg/ml |
Filed |
|
Cardiovascular |
Apixaban
|
|
|
2.5, 5mg |
Filed |
|
Cardiovascular |
Dabigatran
|
|
|
75 , 110, 150 mg |
Filed |
|
Cardiovascular |
Rivaroxaban
|
|
|
10, 15, 20 mg |
Filed |
|
Cardiovascular |
Sacubitril/ Valsartan
|
|
|
24/26, 49/51, 97/103 mg |
Filed |
|
Cardiovascular |
Ticagrelor
|
|
|
60, 90 mg |
Filed |
|
Cardiovascular |
Icosapent Ethy
|
|
|
1 g |
Filed |
|
Anti-Diabetic |
Canagliflozin + Metformin
*This product is not available for commercial use. It would be available only for Section 107A purposes.
|
|
|
150 mg/1000 mg, 150 mg/500 mg, 50mg/1000 mg, 50 mg/500 mg |
Filed |
|
Anti-Diabetic |
Linagliptin
|
|
|
5 mg |
Filed |
|
Anti-Diabetic |
Linagliptin + Metformin
|
|
|
2.5 mg/500 mg, 2.5 mg/850 mg, 2.5 mg/1000 mg |
Filed |
|
Anti-Diabetic |
Liraglutide
|
|
|
6mg/ml – 3 ml fill pen |
Under Development |
|
Anti-Diabetic |
Semaglutide
|
|
|
2mg/1.5mL; 4mg/3mL |
Under Development |
|
Anti-Obesity |
Liraglutide
|
|
|
6mg/ml – 3 ml fill pen |
Under Development |
|
Gastro-Intestinal |
Esomeprazole
|
|
|
20, 40mg |
Filed |
|
Gastro-Intestinal |
Esomeprazole MG + Naproxen Na
|
|
|
20 mg/375 mg, 20 mg/500 mg |
Filed |
|
Gastro-Intestinal |
Lansoprazole ODT
|
|
|
15 mg and 30 mg |
Filed |
|
Immuno Suppressant |
Sirolimus
|
|
|
1 mg and 2 mg |
Filed |
|
Immuno Suppressant |
Tacrolimus
|
|
|
0.5 mg, 1 mg and 5 mg |
Filed |
|
Others |
Daptomycin
|
|
|
350, 500 mg |
Filed |
|
Others |
Icatibant
|
|
|
30 mg base /3 ml PFS |
Filed |
|
Others |
Iron Sucrose
|
|
|
100 mg/5 ml, 200 mg/10 ml, 50 mg/2.5 ml |
Filed |
|
Others |
阿普斯特
|
|
|
10, 20, 30 mg |
Filed |
|
Others |
Sevelamer Carbonate
|
|
|
800 mg |
Filed |
|
Others |
Valganciclovir
|
|
|
450 mg |
Filed |
|
Others |
Isotretinoin
|
|
|
10mg, 20mg, 30mg and 40mg |
Filed |
|
Others |
Varenicline
|
|
|
0.5 mg and 1 mg |
Filed |
|
Others |
Teriparatide
|
|
|
0.6 mg/2.4 mL (0.25 mg/mL) |
Under Development |
|
Others |
Rifaximine
|
|
|
550mg |
Under Development |
|
Others |
Amphotericin B
|
|
|
50mg |
Under Development |
|
Others |
Mesalamine
|
|
|
250 and 500 mg |
Under Development |
|